Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome.
Hannah CeuleersNikita HanningJelena HeirbautSamuel Van RemoortelJurgen JoossensPieter Van Der VekenSven M FrancqueMichelle De BruynAnne-Marie LambeirJoris G De ManJean-Pierre TimmermansKoen AugustynsIngrid De MeesterBenedicte Y De WinterPublished in: British journal of pharmacology (2018)
Increased expression of serine proteases and activity together with increased expression of downstream molecules at the colonic and DRG level and in CGRP-positive sensory nerve fibres imply a role for serine proteases in post-inflammatory visceral hypersensitivity. Our results support further investigation of serine protease inhibitors as an interesting treatment strategy for IBS-related visceral pain.